Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain

Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain

Johanna Lister,1 Sanja Stanisic,1 Klaus Kaier,2 Christian Hagist,2 Dmitry Gultyaev,1 Stefan Walzer31Analytica LA-SER International Inc, Lörrach, Germany; 2Research Centre for Generational Contracts, University of Freiburg, Freiburg, Germany; 3F Hoffmann-La Roche Ltd, Pharmaceuticals Div...

Full description

Bibliographic Details
Main Authors: Lister J, Stanisic S, Kaier K, Hagist C, Gultyaev D, Walzer S
Format: Article
Language:English
Published: Dove Medical Press 2012-10-01
Series:ClinicoEconomics and Outcomes Research
Online Access:http://www.dovepress.com/societal-savings-in-patients-with-advanced-non-squamous-non-small-cell-a11168

Internet

http://www.dovepress.com/societal-savings-in-patients-with-advanced-non-squamous-non-small-cell-a11168

Similar Items